Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kelley Wilson

Psychiatry Tampa, FL Medical Doctor

NPI 1932398757 CMS profile 224261

3101 W Dr Mlk Blvd Ste 110, Tampa, FL 33607

Open in the dashboard

General payments

$7,718

137 records reported · program years 2019–2025

Research payments

$4,146

Paid to them · 3 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$11,055,460 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Kelley Wilson of Tampa, FL is reported in the CMS Open Payments database as having received $7,718 across 137 general payments and $4,146 in research payments paid to them. Separately, studies naming them as principal investigator received $11,055,460 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $717 3
2024 General $684 29
2023 General $1,820 73
2023 Research $1,040 1
2022 General $389 8
2022 Research $1,428 1
2021 General $269 10
2021 Research $1,678 1
2020 General $65 3
2019 General $3,773 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kelley Wilson
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Kelley Wilson were reported at $717. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Kelley Wilson Psychiatry median Middle half National median
2019 $3,773 $184 $59–$605 $163
2020 $65 $119 $36–$372 $114
2021 $269 $143 $43–$576 $132
2022 $389 $153 $50–$590 $149
2023 $1,820 $170 $56–$651 $160
2024 $684 $179 $57–$673 $164
2025 $717 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Janssen Pharmaceuticals, Inc $2,863 8 payments
  2. Neuronetics, Inc. $1,048 8 payments
  3. Eli Lilly and Company $662 2 payments
  4. ITI, Inc. $429 14 payments
  5. Alkermes, Inc. $294 10 payments
  6. AbbVie, Inc. $287 8 payments
  7. Neos Therapeutics, LP $277 10 payments
  8. Corium, Inc. $261 8 payments
  9. Otsuka America Pharmaceutical, Inc. $221 11 payments
  10. Noven Therapeutics, LLC $209 11 payments
  11. Other $1,167 47 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,869 131 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,600 2 payments
  3. Travel and Lodging $1,199 3 payments
  4. Education $49 1 payment
Products named General payments · program years 2019–2025
  1. SPRAVATO $2,840 7 payments
  2. NEUROSTAR TMS THERAPY $1,048 8 payments
  3. CAPLYTA $429 14 payments
  4. LYBALVI Cns $294 10 payments
  5. VRAYLAR $287 8 payments
  6. Adzenys XR-ODT $277 10 payments
  7. Azstarys $261 8 payments
  8. LYBALVI Cns $219 6 payments
  9. LYBALVI Cns $219 6 payments
  10. LYBALVI Cns $219 6 payments
  11. Other $2,236 108 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Eli Lilly and Company $4,146 3 payments

Records

140 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record